Britain: The “Oxford-AstraZeneca” vaccine must be reviewed before it is officially launched
London – (Reuters):
On Sunday, the British Ministry of Health said that the Medicines and Healthcare products Regulatory Agency should be given time to conduct a review of data for the Oxford-AstraZeneca Coronavirus vaccine.
“We must give the Medicines and Healthcare Products Regulatory Agency the time now to do its important work, and we must wait for its recommendations,” a ministry spokeswoman said.
The spokeswoman was responding to a report by the Sunday Telegraph, which stated that Britain would introduce the vaccine from January 4, according to plans drawn up by ministers.
The newspaper said that the government hopes to give the first dose of the Oxford vaccine, which AstraZeneca obtained a license to produce, or the Pfizer vaccine for two million within the next two weeks. She added that medical regulators are expected to approve the Oxford vaccine within days.